Biopsy, Salivary Gland
Sampling of the salivary gland tissue is required in the clinical management of various neoplastic and non-neoplastic conditions. When a neoplastic lesion is suspected, a fine needle aspiration (FNA) biopsy is performed to confirm the suspicion and choose an appropriate surgical procedure. Incisional biopsy is generally reserved for the management of Sjögren's syndrome or other inflammatory conditions.
FNA is a relatively simple procedure and can be performed in an outpatient setting under a local anesthesia. After appropriate patient preparation, a fine needle is introduced through the skin either using manual localization or using ultrasound guidance. Once the needle is in the lesion, tissue is aspirated through suction. After obtaining adequate sampling, hemostasis is achieved by applying pressure gauze pads. Incisional biopsies are generally performed in the operating rooms by surgeons under local/regional anesthesia. The procedures are generally well tolerated. Most patients experience mild pain and discomfort at the biopsy site and transient hypoesthesia of the lip/mouth. Rare complications include arterial bleeding/hematoma, vasovagal collapse, paresthesia and infectious complications.
- Diagnosis and management of salivary gland tumors
- Diagnosis and management of Sjögren's syndrome and other systemic diseases such as sarcoidosis, amyloidosis, etc.
There are no universal reference ranges for salivary gland biopsy specimens. In general, a normal salivary gland tissue consists of benign glandular and ductal epithelium embedded in a fibrovascular connective tissue stroma.
Biopsies and cytology samples are obtained by an interventional radiologist or a surgeon. Biopsy specimens are placed directly in formalin fixative. Cytology samples need to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory. Rarely, culture is indicated and tissue for culture should be sent in a sterile container to the laboratory for microbiological assessment.
- Rheumatology (Oxford). 2010 Nov;49(11):2117-21. [PMID: 20660500]
- Acta Cytol. 2014;58(6):552-62. [PMID: 25171320]
- Cancer Cytopathol. 2016 May;124(5):307-16. [PMID: 26539897]
- Acta Cytol. 2001 Jul-Aug;45(4):567-74. [PMID: 11480720]
- Arch Pathol Lab Med. 2015 Dec;139(12):1491-7. [PMID: 26619021]